Yen-Chou (YC) Chen

Cardiologist | Healthcare Strategist | Data Scientist
Cardio-Oncology | Heart Failure| Cardiac Imaging

[Javid Moslehi @CardioOncology]

Excited to report this important collaboration which we hope helps us understand ICI-myocarditis better, published in #EHJ today! Along with the great @DrJESalem! @ehj_ed @JBauersachsMD #CardioOnc @UCSFCardiology @UCSFCancer

https://t.co/3jsZaZ2SuQ

[Javid Moslehi @CardioOncology]

YC @drycm2d was the first fellow 2 complete #CardioOnc fellowship w/ me when I moved to @UCSFCardiology 3 years ago. Trained as a cardiologist in Taiwan but also an MBA from @UNC! Now establishing the first leading #CardioOnc program @TaipeiMedicalU! Here he is during graduation!

[Javid Moslehi @CardioOncology]

Finally, we are recruiting fellows for 2026 at UCSF for #CardioOnc & Immunology! Also looking for those w/ basic and translational interest (&background)! Who wants to join this distinguished group of fellows & alumni? Email me if interested: [email protected]

[Javid Moslehi @CardioOncology]

Congrats 2 former #UCSF #CardioOnc fellow @drycm2d leading this terrific publication on left ventricular systolic dysfunction in Immune Checkpoint Inhibitor (ICI)-myocarditis in @JACCJournals along w/ @vgzmd @DrJESalem & many others!

https://t.co/rGsghFte9F

[DrJE-Salem @DrJESalem]

From the international ICI-myocarditis registry - Left Ventricular Systolic Dysfunction at presentation capture both past medical history ofcardiac insults and immune checkpoint myocarditis severity @CardioOncology @HanZhuMD @salimhayek @jelevenson @vgzm https://t.co/TshDIa3fdZ

[JAHA @JAHA_AHA]

A nested case-control study design and data from Taiwan Cancer Registry show that, among cancer patients in Taiwan, angiogenesis inhibitors were associated with increased risks of cardiac+thromboembolic events. #AHAJournals @hfi529 @drycm2d @TaipeiMedicalU https://t.co/6t7ZwTb3hA

[Javid Moslehi @CardioOncology]

Nice sendoff to the one & only @drycm2d! Great & productive year in #MoslehiLab & @UCSFCardiology #CardioOnc Section! Of course, a sendoff would not be complete without a @TASCHEN San Francisco book & some @MoshiMoshiSF sushi! @TaipeiMedicalU @UCSFCancer

[Javid Moslehi @CardioOncology]

Congrats 2 @drycm2d for becoming the first #CardioOnc fellow I trained at @UCSF! Nice graduation ceremony at @StFYC! Dr. Chen will be #CardioOnc program leader at Taipei Medical University Hospital! Look forward to years of collaboration!
@TaipeiMedicalU
@AmirZMunir

[Javid Moslehi @CardioOncology]

A+ #CardioOnc Special Issue @JMCCardiology on line! Pleasure to co-lead this effort w/ @AartiAsnaniMD!
Thanks 2
@Rongtian2
@KathrynMooreLab
@baik_alan
@yurikim_mdphd
@vgzmd
@LorenzLehmann
@HanZhuMD
@SeanM_Wu
@pnatarajanmd
@AlexBickMDPhD
@MichaelRegnier9
https://t.co/xRvksDcEXP

[Javid Moslehi @CardioOncology]

Last clinic w/ the great @drycm2d as @UCSFCardiology #CardioOnc fellow. Dr. Chen will be program leader in cardio-oncology at Taipei Medical University Hospital & important part of the ICI-myocarditis registry. Look forward to years of collaboration! @TaipeiMedicalU @AmirZMunir

[Yen-Chou (YC) Chen @drycm2d]

A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of Immunotherapy in Melanoma. https://t.co/4zf6TIqCWS

[Javid Moslehi @CardioOncology]

Real pleasure 2 have Dr. Charles Dolladille @CardioOncoCaen visit @UCSF & our #CardioOnc section this past month. Excited about the many collaborations btwn @UCSFCardiology & the French #CardioOnc teams! Lots of cool projects coming 2 fruition in the coming months! @DrJESalem

[Javid Moslehi @CardioOncology]

Figure by @lylybellz @drycm2d for a manuscript illustrating novel immune checkpoints (eg, Lag3). At @UCSFCardiology #CardioOnc/Immunology Section we are studying the CV functions of these molecules. Always looking for new talent! Let me know if you want 2 learn more!

[John Mandrola, MD @drjohnm]

Love this —> Twitter need not always be about dessert. Eat your vegetables 👇🏻👇🏻

[JACC Journals @JACCJournals]

How do we reason through real-world conundrums in the cardiac care of childhood cancer survivors? Read about the potential roadmaps for #cardiomyopathy care in this issue of #JACCCardioOnc: https://t.co/7ZYl0hz1Dv

#CardioOnc #cvPed #CardioTwitter #childhoodcancer @DrThomasRyan

[European Society of Cardiology Journals @ESC_Journals]

Outcomes after out-of-hospital cardiac arrest – despite the positive trend, is there as much improvement as desired? A retrospective analysis of >1.7M patients over 15-yr in https://t.co/DcWql4V7Jn

#EHJQCCO #OHCA @cpgale3 @diogoasantosfer

[JACC Journals @JACCJournals]

.@ACCinTouch's newest Expert Consensus Decision Pathway, just published in #JACC, offers a comprehensive and integrative framework for treating patients with #ASCVD and multimorbidity. https://t.co/NAa1aP4OEx

#ACCClinicalDoc #CardioTwitter @kofi_larry @virani_md @tygluckman

[Wonder of Science @wonderofscience]

Fascinating footage of a human white blood cell chasing a bacterium captured through a microscope. Credit: David Rogers

[JACC Journals @JACCJournals]

Certain CD4+ T-Cell types were significantly associated with incident CVD, not explained by traditional risk factors. https://t.co/o4c7LWL9XN

#JACC #Tcell #CVD #HIV #CardioTwitter

[Javid Moslehi @CardioOncology]

Breathtaking picture depicting ICI-myocarditis in collaboration w/ Drs. Lin & Yang at @MDAndersonNews! Green represents immune infiltrates in the heart. For the first time, we are beginning to understand why sex differences occur in myocarditis! #CardioOnc #CardioImmunology